Literature DB >> 3060827

Insulin resistance in a boy with congenital generalized lipodystrophy.

H Tsukahara1, K Kikuchi, H Kuzuya, E Ito, Y Oda, A Kosaki, T Kakehi, H Nishimura, K Yamada, Y Yoshimasa.   

Abstract

We have studied insulin resistance in a 12-year-old Japanese boy who presented with congenital generalized lipodystrophy. Oral glucose tolerance test exhibited a diabetic pattern with normal fasting plasma glucose. Results from euglycemic glucose clamp study showed decreases in both insulin sensitivity and responsiveness. Both the patient's erythrocytes and Epstein-Barr virus transformed lymphocytes showed low-normal insulin binding with a slight reduction in binding affinity in the latter. Insulin binding to the cultured fibroblasts was decreased due to a lowered affinity. In addition, they displayed a rightward shift of the insulin dose-response curve for D-14C-glucose uptake with no decrease in the maximum uptake. Insulin-stimulated autophosphorylation and kinase activity of the wheat germ agglutinin purified receptors from the Epstein-Barr virus-transformed lymphocytes appeared normal. The reason for some discrepancies in insulin binding among the cells remains unknown, and we cannot formulate a conclusion as to whether or not a primary binding defect of insulin receptors exists and contributes to insulin resistance in the patient. The decrease in insulin responsiveness demonstrated in the glucose clamp study may result from a defect at the rate-limiting step in the postbinding process of insulin action, presumably a defect in the glucose transport system in muscle tissues. The defect may be secondary to changes in in vivo circumstances.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3060827     DOI: 10.1203/00006450-198812000-00003

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  1 in total

1.  The development of hyperglycaemia in patients with insulin-resistant generalized lipoatrophic syndromes.

Authors:  J J Robert; B Rakotoambinina; I Cochet; V Foussier; J Magre; D Darmaun; D Chevenne; J Capeau
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.